Literature DB >> 1555743

Fulminant hepatitis--is the survival improving?

Y Muto.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1555743

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN： 0435-1339


× No keyword cloud information.
  9 in total

1.  Late onset hepatic failure: clinical, serological and histological features.

Authors:  A E Gimson; J O'Grady; R J Ede; B Portmann; R Williams
Journal:  Hepatology       Date:  1986 Mar-Apr       Impact factor: 17.425

2.  The fulminant hepatic failure surveillance study. Brief review of the effects of presumed etiology and age of survival.

Authors:  C Trey
Journal:  Can Med Assoc J       Date:  1972-02-26       Impact factor: 8.262

3.  Acute hepatic failure--in special relation to treatment.

Authors:  Y Takahashi
Journal:  Jpn J Med       Date:  1983-04

4.  Early indicators of prognosis in fulminant hepatic failure.

Authors:  J G O'Grady; G J Alexander; K M Hayllar; R Williams
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

5.  Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay.

Authors:  H Tsubouchi; Y Niitani; S Hirono; H Nakayama; E Gohda; N Arakaki; O Sakiyama; K Takahashi; M Kimoto; S Kawakami
Journal:  Hepatology       Date:  1991-01       Impact factor: 17.425

6.  Determination of the integrated CT number of the whole liver in patients with severe hepatitis: as an indicator of the functional reserve of the liver.

Authors:  T Kumahara; Y Muto; H Moriwaki; T Yoshida; E Tomita
Journal:  Gastroenterol Jpn       Date:  1989-06

7.  Vigorous medical management of acute fulminant hepatitis.

Authors:  M O Auslander; G L Gitnick
Journal:  Arch Intern Med       Date:  1977-05

Review 8.  Liver transplantation for acute hepatic failure?

Authors:  R W Chapman; D Forman; R Peto; R Smallwood
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

9.  Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report.

Authors:  S B Sinclair; P D Greig; L M Blendis; M Abecassis; E A Roberts; M J Phillips; R Cameron; G A Levy
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.